Status:
COMPLETED
Swiss Prospective, Multicenter Study Sentinel Lymph Node Procedure in Colon Cancer
Lead Sponsor:
University Hospital, Basel, Switzerland
Conditions:
Colonic Neoplasms
Eligibility:
All Genders
Phase:
PHASE1
PHASE2
Brief Summary
The study is a feasibility and validation study of the sentinel lymph node (SLN) procedure in all stages of colon cancer. If the SLN can be reliably identified, it could be submitted to a more accurat...
Eligibility Criteria
Inclusion
- Colon cancer at any stage diagnosed histologically or high degree of suspicion for colon cancer at endoscopy, which cannot be confirmed with certainty in the biopsy. The diagnosis of cancer must be certain in the definitive histology.
- Possibility of transabdominal injection of the dye (cancers below the peritoneal reflection in which the injection of dye must be carried out through rectoscopy, are therefore excluded).
- Patient's informed consent
Exclusion
- Prior intrabdominal tumor surgery
- Other preexisting malignancies
- Hypersensitivity/allergy to dye (isosulfan blue)
- Pregnancy
- Breast-feeding
- No patient's informed consent
Key Trial Info
Start Date :
May 1 2000
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2009
Estimated Enrollment :
192 Patients enrolled
Trial Details
Trial ID
NCT00826579
Start Date
May 1 2000
End Date
January 1 2009
Last Update
March 12 2015
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Carsten T. Viehl, MD
Basel, Switzerland, 4031
2
Urban Laffer, MD
Biel, Switzerland, 2501
3
Markus Zuber, MD
Olten, Switzerland, 4600